Follow-The-Filings

Security · featured owners

ROIV Roivant Sciences Ltd

Health Care SHS Equity as of 2026 Q2 among managers we track

  • 6 Owners
  • #259
  • Max 2.3%
  • Master 0.05%
  • $909M
  • 1 new 2 add 1 reduce

ROIV (Roivant Sciences Ltd) is held in 6 featured 13F books as of 2026 Q2. Farallon Capital Management is the largest tracked holder by portfolio weight (2.3%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 2.3% (Farallon Capital Management) · not free-float ownership

  1. Farallon Capital Management Add 2.3%
  2. David Einhorn 2.0%
  3. Lee Ainslie Add 0.88%
  4. Andreas Halvorsen Reduce 0.63%
  5. Ron Baron 0.01%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management 2026 Q2 2.3% Add +47.9% 14,309,000 $506M History
Andreas Halvorsen - Viking Global Investors 2026 Q2 0.63% Reduce −5.7% 6,271,467 $222M History
Lee Ainslie - Maverick Capital 2026 Q2 0.88% Add +73.9% 2,829,024 $100M History
David Einhorn - DME Capital Management 2026 Q2 2.0% Hold 2,152,669 $76M History
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 0.01% Hold 125,000 $4M History
Polen Capital Management 2026 Q2 <0.01% New <0.01% 8,659 $306K History

6 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.07,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Sep 20, 2026 · 2 forms Filing Doc
4 Period Sep 16, 2026 · 6 forms Filing Doc
4 Period Sep 15, 2026 · 2 forms Filing Doc
4 Period Sep 10, 2026 · 5 forms Filing Doc
4 Period Sep 8, 2026 Filing Doc
4 Period Aug 28, 2026 Filing Doc
4 Period Aug 20, 2026 · 2 forms Filing Doc
4 Period Aug 19, 2026 Filing Doc
4 Period Aug 14, 2026 Filing Doc
4 Period Jul 27, 2026 Filing Doc
4 Period Jul 17, 2026 · 3 forms Filing Doc

Updated 7 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $61.28M $32.71M $29.05M
Net income -$1.01B $4.35B -$0.172B
Net margin * -1646.6% 13294.2% -592.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.8B $6.73B $5B
Total non-current assets * $591.02M $490.65M $436.88M
Total assets $2.39B $7.22B $5.44B
Total current liabilities $272.45M $266.76M $149.41M
Total non-current liabilities * $509.57M $507.2M $100.33M
Total equity $1.16B $5.97B $4.69B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$843.39M -$765.27M -$839.45M
Cash from investing -$0.044B $5.2B -$1.77B
Cash from financing $0.499B $0.419B -$1.22B
Net change in cash -$0.382B $4.86B -$3.82B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders